MEDP · Medpace Holdings Inc
United States · RS rating 88 · As of 2026-11-03
| Price | 663.49 USD |
|---|---|
| 1-day change | +2.4% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 76 / 84 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 56 / 58 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +21.0% |
| Sales growth Q/Q | +7.4% |
| Distance from 52-week high | +4.2% |
| Market cap (USD) | $11.2B |